Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LDL-C”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01763918
What this trial is testing

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Who this might be right for
Hyperlipidemia
Amgen 331
Post-approval studies (Phase 4)Active Not RecruitingNCT04951856
What this trial is testing

Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI

Who this might be right for
STEMI - ST Elevation Myocardial InfarctionNSTEMI - Non-ST Segment Elevation MI
Assistance Publique - Hôpitaux de Paris 2,166
Large-scale testing (Phase 3)Study completedNCT04873934
What this trial is testing

Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Novartis Pharmaceuticals 400
Early research (Phase 1)Not Yet RecruitingNCT07001787
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10510 in Healthy Subjects

Who this might be right for
Dyslipidemia
Jiangsu Hansoh Pharmaceutical Co., Ltd. 88
Post-approval studies (Phase 4)UnknownNCT02077257
What this trial is testing

LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients

Who this might be right for
Acute Coronary Syndrome
Committee of Cardio-Cerebral-Vascular Diseases of GSC 1,060
Not applicableStudy completedNCT02341664
What this trial is testing

Patient and Provider Assessment of Lipid Management Registry

Who this might be right for
HyperlipidemiaHypercholesterolemiaCardiovascular Disease+14 more
Duke University 7,658
Not applicableStudy completedNCT06782243
What this trial is testing

Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Khyber Medical University Peshawar 190
Testing effectiveness (Phase 2)Looking for participantsNCT07368608
What this trial is testing

BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol（LDL-C）

Who this might be right for
Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol
BeBetter Med Inc 340
Not applicableStudy completedNCT04975048
What this trial is testing

SREBF1 Polymorphism and Egg Yolk on Cardiovascular Disease Risk in Healthy Young Adults: a Randomised, Two-period, Single Blinded, Crossover Trial

Who this might be right for
HealthyGEN1 Gene Mutation
Shandong University 64
Post-approval studies (Phase 4)Study completedNCT04030247
What this trial is testing

Impact of Plant Sterol Supplement on LDL-C Lowering in Low-to-Moderate Risk South Asian Patients

Who this might be right for
Cardiovascular Risk Factor
Stanford University 50
Early research (Phase 1)Study completedNCT03427710
What this trial is testing

A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level

Who this might be right for
Hypercholesterolemia
Civi Biopharma, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT04069715
What this trial is testing

The Effect of Farlong® NotoGinseng™ (Ginseng Plus®) on Cholesterol and Blood Pressure

Who this might be right for
HyperlipidemiasHypertension
LongStar HealthPro, Inc. DBA Farlong Pharmaceutical 95
Testing effectiveness (Phase 2)Study completedNCT03933293
What this trial is testing

Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFH

Who this might be right for
Homozygous Familial Hypercholesterolemia
Akeso 10
Not applicableNot Yet RecruitingNCT05587621
What this trial is testing

Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)

Who this might be right for
ST Elevation Myocardial InfarctionNon-ST Elevation Myocardial InfarctionLDL-cholesterol
Jena University Hospital 300
Not applicableStudy completedNCT03523247
What this trial is testing

A Whole Food Plant Diet and Its Lipidemic Effects on Primary Prevention in a Free-range Population

Who this might be right for
Diet ModificationCardiology
Lancaster General Hospital 50
Not applicableActive Not RecruitingNCT05399992
What this trial is testing

Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 847
Large-scale testing (Phase 3)Looking for participantsNCT06813911
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals 340
Large-scale testing (Phase 3)Study completedNCT01763528
What this trial is testing

High Protein Weight Loss Diet, High Sensitivity C-Reactive Protein and Cardiovascular Risks Among Obese Women

Who this might be right for
Body Mass Index Quantitative Trait Locus 8 DisorderTangier Disease
Isfahan University of Medical Sciences 63
Not applicableEnded earlyNCT00525083
What this trial is testing

Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C

Who this might be right for
Hyperlipidemia
Vanderbilt University Medical Center 19
Early research (Phase 1)Study completedNCT02314442
What this trial is testing

An Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Hypercholesterolemia
Alnylam Pharmaceuticals 70
Next Page